About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Baltimore | 13,717 Studies Near You

Clinical TrialsBaltimore

Clinical Trials in Baltimore

Discover 13,717 clinical trials near Baltimore, Maryland. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 6801-6820 of 13,717 trials

Active not recruitingBortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple MyelomaThis randomized phase III trial studies bortezomib, lenalidomide, and dexamethasone to see how well they work compared to carfilzomib, lenalidomide, and dexamethasone in treating…NCT01863550·Anchorage, Alaska and 919 others

Find Trials by Condition in Baltimore

Breast Cancerin Baltimore Lung Cancerin Baltimore Prostate Cancerin Baltimore Colorectal Cancerin Baltimore Melanomain Baltimore Leukemiain Baltimore Lymphomain Baltimore Pancreatic Cancerin Baltimore Ovarian Cancerin Baltimore Brain Cancerin Baltimore

Data from ClinicalTrials.govTerms

CompletedEntecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) InfectionThe purpose of this study is to determine the safety and efficacy of treatment using a combination of drugs (entecavir and pegylated interferon) in children ages 3-\<18 years old…NCT01368497·San Francisco, California and 6 others

CompletedStudy of AA4500 in the Treatment of Peyronie's DiseaseThis study is a Phase 3, double-blind, randomized, placebo-controlled study of the safety and efficacy of AA4500 0.58 mg in subjects with Peyronie's disease.NCT01221597·Homewood, Alabama and 33 others

CompletedA Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)This is a Phase 1b, open-label, non-randomized, multicenter, dose-finding study evaluating venetoclax in combination with azacitidine in participants with treatment-naïve…NCT02942290·Tucson, Arizona and 36 others

Active not recruitingLeveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver TransplantCan the investigators create an effective way to improve adherence to immunosuppressant medication and reduce rejection, graft loss, and death in adolescents and young adults who…NCT05613010·Baltimore, Maryland

CompletedStudy to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available MedicationsThe purpose of this study is to estimate the rate of sustained virologic response (SVR) SVR12, where SVR12 is defined as HCV RNA \< LOQ (detectable or undetectable) 12 weeks…NCT01455090·Birmingham, Alabama and 31 others

CompletedImplementation of Function Focused Care in Acute CareOlder adults with Alzheimer's Disease and Related Dementias (ADRD) comprise approximately 25% of hospitalized older adults.NCT04235374·Annapolis, Maryland and 13 others

CompletedA Trial to Evaluate Safety, Tolerability and Efficacy of Elamipretide in Subjects With Barth SyndromeA randomized, double-blind cross over trial to evaluate the safety, efficacy, and tolerability of elamipretide in subjects with Barth syndrome.NCT03098797·Baltimore, Maryland

RecruitingValidation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield TrialsVERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore these biomarkers in…NCT05338697·Birmingham, Alabama and 44 others

CompletedStudy of the Abuse Liability of Oxycodone HCl/Niacin in Subjects With a History of Opioid AbuseThe purpose of this study is to assess the abuse liability of 4 times (8 tablets) the usual recommended dose of Acurox (oxycodone HCl 40 mg plus niacin 240 mg) versus oxycodone…NCT00699010·Baltimore, Maryland

UnknownLomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)This study is designed to assess the safety, tolerability, and efficacy of Lomecel-B as an adjunct therapy to the standard stage II (BDCPA) surgical intervention for HLHS.NCT03525418·Atlanta, Georgia and 4 others

RecruitingSyk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific AntibodiesBackground: People who have lung transplants often survive 6 or 7 years.NCT06948097·Stanford, California and 3 others

CompletedSafety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and ChildrenHuman parainfluenza viruses (HPIVs) are a major health concern in infants and young children under 5 years of age, causing serious respiratory tract disease.NCT01021397·Baltimore, Maryland and 1 other

TerminatedPhase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's LymphomaPatients with previously untreated low tumor burden indolent Non-Hodgkin's Lymphoma (NHL) will receive either rituximab or GA101 weekly for 4 weeks followed by re-staging to…NCT01889797·Mobile, Alabama and 27 others

Completed89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON Study89Zr-TLX250 is under clinical development as a diagnostic agent targeting clear cell renal cell carcinoma.NCT03849118·Duarte, California and 30 others

TerminatedStudy Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5/X4-Tropic Treatment-Experienced HIV-Infected SubjectsThe purpose of this study is to evaluate the safety and efficacy of the CCR5 antagonist GW873140 or placebo in combination with an optimized background regimen in…NCT00197197·Los Angeles, California and 11 others

CompletedStudy to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure (ATOMIC-AHF)The primary objective of the study is to evaluate the effect of 48 hours of intravenous (IV) omecamtiv mecarbil compared with placebo on dyspnea in subjects with left ventricular…NCT01300013·Mobile, Alabama and 149 others

CompletedAntiphospholipid Syndrome Collaborative Registry (APSCORE)Antiphospholipid Syndrome (APS) is an autoimmune disorder in which the body recognizes certain normal components of blood and/or cell membranes as foreign substances and produces…NCT00076713·Atlanta, Georgia and 6 others

CompletedEndoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy - Part 2Rapid metabolic improvements seen with sleeve gastrectomy are likely a result of changes in gastric origin.NCT03638843·Baltimore, Maryland

CompletedProspective Aneurysm Trial: High Angle Aorfix™ Bifurcated Stent GraftPurpose of this study: The purpose of the study is to evaluate the safety and effectiveness of the Lombard Medical endovascular Aorfix™ AAA bifurcated stent graft in the treatment…NCT00522535·Birmingham, Alabama and 37 others

PreviousPage 341 of 686Next

Diabetes

in Baltimore

Heart Diseasein Baltimore